Title:Melittin: A Natural Peptide with Expanded Therapeutic Applications
Volume: 12
Issue: 2
Author(s): Ruchi Tiwari*, Gaurav Tiwari, Akanksha Lahiri, Vadivelan Ramachandran and Awani Rai
Affiliation:
- Department of Pharmacy, Pranveer Singh Institute of Technology, Kalpi Road, Bhauti, Kanpur- 208020, India
Keywords:
BV, Melittin, anti-cancer activity, anti-microbial activity, anti-viral activity, anti-inflammatory activity, anti-diabetic activity, mechanism of action.
Abstract: Background: Apis mellifera, European honey bee venom (BV), is a complex combination
of chemical compounds comprising proteins, peptides, enzymes, and other small molecules.
Melittin (MEL), which is the key component of BV, is considered as an alternative for the treatment
of various infections. MEL is an amphipathic, cell-penetrating, 26-residue, a-helical anti-hepatoma
peptide derived from BV. However, owing to its initial conformational strength and poor stability,
the use of melittin is constrained as a medication.
Objectives: The study focused on collective data of therapeutic activities of Bee venom component,
MEL.
Methods: Regardless of its broad variety of biological and possible therapeutic uses, there has been
increasing concern regarding the use of MEL. According to the literature, MEL revealed a variety
of activities ranging from anti-cancer, antimicrobial, anti-viral, anti-inflammatory to anti-diabetic
activity. The present review article summarizes the therapeutic applications of MEL, their mechanism
of action along with recent research progress in the field of its delivery.
Conclusion: It could be concluded that MEL exerts multiple effects on the cellular functions of infected
cells.